Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.
colorectal cancer screening
faecal immunochemical testing
participation
sigmoidoscopy
socioeconomic status
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
revised:
23
03
2022
received:
25
01
2022
accepted:
01
04
2022
pubmed:
13
4
2022
medline:
9
6
2022
entrez:
12
4
2022
Statut:
ppublish
Résumé
Public health systems should guarantee universal access to health care services, including cancer screening. We assessed whether certain population subgroups were underrepresented among participants in colorectal cancer screening with sigmoidoscopy and faecal immunochemical testing (FIT). Between 2012 and 2019, about 140 000 individuals aged 50 to 74 years were randomly invited to once-only sigmoidoscopy or first round of FIT screening. Our study included 46 919 individuals invited to sigmoidoscopy and 70 019 to FIT between 2012 and 2017. We used logistic regression models to evaluate if demographic and socioeconomic factors and use of certain drugs were associated with participation. Twenty-four thousand one hundred and fifty-nine (51.5%) individuals attended sigmoidoscopy and 40 931 (58.5%) FIT screening. Male gender, young age, low education and income, being retired or unemployed, living alone, being an immigrant, long driving time to screening centre, and use of antidiabetic and psychotropic drugs were associated with low participation in both screening groups. Many of these factors also predicted low acceptance of colonoscopy after positive FIT. While male gender, young age and living alone were more strongly associated with nonparticipation in FIT than sigmoidoscopy, low education and income, being retired or immigrant and long driving time were more strongly associated with nonparticipation in sigmoidoscopy than FIT. In conclusion, participation was lower in sigmoidoscopy than FIT. Predictors of nonparticipation were similar between arms. However, low socioeconomic status, being an immigrant and long driving time affected participation more in sigmoidoscopy screening, suggesting that FIT may guarantee more equal access to screening services than sigmoidoscopy.
Identifiants
pubmed: 35411554
doi: 10.1002/ijc.34025
pmc: PMC9324830
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
361-371Informations de copyright
© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Clin Epidemiol. 2018 Nov 23;10:1733-1742
pubmed: 30538577
Eur J Public Health. 2021 Apr 24;31(2):340-346
pubmed: 33417705
Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):14-22
pubmed: 33223399
Eur J Public Health. 2021 Oct 11;31(4):890-894
pubmed: 34347069
Int J Cancer. 2017 Apr 15;140(8):1770-1780
pubmed: 28063159
Cancer Causes Control. 2014 Aug;25(8):985-97
pubmed: 24859111
Health Econ. 2009 Mar;18(3):337-54
pubmed: 18677722
Int J Colorectal Dis. 2017 Aug;32(8):1117-1124
pubmed: 28501944
J Clin Med. 2020 Jan 18;9(1):
pubmed: 31963658
J Med Screen. 2020 Jun;27(2):59-67
pubmed: 31690179
Cancers (Basel). 2020 May 29;12(6):
pubmed: 32486077
J Med Screen. 2021 Jun;28(2):114-121
pubmed: 32295488
Sci Rep. 2020 Feb 12;10(1):2441
pubmed: 32051454
PLoS One. 2017 Jun 16;12(6):e0179864
pubmed: 28622365
Am J Med. 2017 Jan;130(1):93.e1-93.e7
pubmed: 27591183
Gastroenterology. 2021 Mar;160(4):1085-1096.e5
pubmed: 33227280
Acta Oncol. 2020 Nov;59(11):1300-1307
pubmed: 32924698
BMC Cancer. 2017 Aug 7;17(1):524
pubmed: 28784093
Int J Cancer. 2022 Aug 1;151(3):361-371
pubmed: 35411554
Prev Med. 2018 Jan;106:185-193
pubmed: 29109015
Lancet. 1971 Feb 27;1(7696):405-12
pubmed: 4100731
Dig Endosc. 2016 Apr;28(3):243-9
pubmed: 26595883
Prev Med Rep. 2021 Jan 04;21:101308
pubmed: 33505841
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Gastrointestin Liver Dis. 2021 Jun 18;30(2):267-273
pubmed: 33951118
Dis Colon Rectum. 2018 Apr;61(4):417-418
pubmed: 29521819
JAMA Netw Open. 2022 Feb 1;5(2):e2146863
pubmed: 35119462
Int J Colorectal Dis. 2021 Oct;36(10):2215-2225
pubmed: 34331119
Am J Gastroenterol. 2020 Dec;115(12):1940-1949
pubmed: 32773458
J Med Screen. 2020 Sep;27(3):121-129
pubmed: 31801039
Psychooncology. 2020 Aug;29(8):1237-1247
pubmed: 32539187